Guidelines for the detection and treatment of liver metastases of colorectal cancer

被引:12
作者
Abad, A. [1 ]
Figueras, J. [2 ]
Valls, C. [3 ]
Carrato, A. [4 ]
Pardo, F. [5 ]
Diaz-Rubio, E. [6 ]
Aranda, E. [7 ]
机构
[1] Univ Hosp Germans Trias & Pujol, Catalan Inst Oncol, Med Oncol Serv, ES-08916 Barcelona, Spain
[2] Hosp Josep Trueta, Dept Surg, Girona, Spain
[3] Hosp Univ Bellvitge, Dept Radiol, Barcelona, Spain
[4] Hosp Gen Univ, Med Oncol Serv, Alicante, Spain
[5] Univ Navarra Clin, Dept Surg, Pamplona, Spain
[6] Hosp Clin San Carlos, Med Oncol Serv, Madrid, Spain
[7] Hosp Univ Reina Sofia, Med Oncol Serv, Cordoba, Spain
关键词
colorectal cancer; liver metastases; surgical treatment; neoadjuvant chemotherapy;
D O I
10.1007/s12094-007-0129-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The spread of the surgical treatment for hepatic metastases have been crucial in the improvement of treatment and survival of metastatic colorectal cancer. The early and accurate diagnosis of metastases and the assessment of their size are essential factors to reach the optimal results with this treatment strategy. The precise indication of the surgical technique with or without the previous administration of neoadjuvant chemotherapy is of significant importance for the choice of R0 surgery and the timing of intervention. Although there is an agreement regarding some parameters related to diagnosis techniques and surgical criteria such as the bilobar extension, the size of the remaining liver post-surgical removal and the indication of pre-operatory chemotherapy, it is necessary to consider all these factors to set up standard criteria and optimize the results. In this article we review all these parameters, from disease follow up to detect metastatic dissemination to the basic criteria for use of neoadjuvant chemotherapy, in order to suggest some general recommendations of evidence level II and recommendation grade A.
引用
收藏
页码:723 / 730
页数:8
相关论文
共 39 条
[1]  
ABAD A, 2007, ACTA ONCOLO IN PRESS
[2]  
Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71
[3]   Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases [J].
Adam, R .
ANNALS OF ONCOLOGY, 2003, 14 :13-16
[4]   Tumor progression while on chemotherapy - A contraindication to liver resection for multiple colorectal metastases? [J].
Adam, R ;
Pascal, G ;
Castaing, D ;
Azoulay, D ;
Delvart, V ;
Paule, B ;
Levi, F ;
Bismuth, H .
ANNALS OF SURGERY, 2004, 240 (06) :1052-1064
[5]  
Adam R, 2001, ANN SURG ONCOL, V8, P347
[6]   Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: A North Central Cancer Treatment Group Phase II study [J].
Alberts, SR ;
Horvath, WL ;
Stcrnfeld, WC ;
Goldberg, RM ;
Mahoney, MR ;
Dakhil, SR ;
Levitt, R ;
Rowland, K ;
Nair, S ;
Sargent, DJ ;
Donohue, JH .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) :9243-9249
[7]  
[Anonymous], 2003, J NATL COMPR CANC NE, V1, P40
[8]   Colorectal liver metastases: CT, MR imaging, and PET for diagnosis - Meta-analysis [J].
Bipat, S ;
van Leeuwen, MS ;
Comans, EFI ;
Pijl, MEJ ;
Bossuyt, PMM ;
Zwinderman, AH ;
Stoker, J .
RADIOLOGY, 2005, 237 (01) :123-131
[9]   Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year [J].
de Baere, T ;
Elias, D ;
Dromain, C ;
El Din, MG ;
Kuoch, V ;
Ducreux, M ;
Boige, V ;
Lassau, N ;
Marteau, V ;
Lasser, P ;
Roche, A .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 175 (06) :1619-1625
[10]   Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer [J].
de Gramont, A ;
Figer, A ;
Seymour, M ;
Homerin, M ;
Hmissi, A ;
Cassidy, J ;
Boni, C ;
Cortes-Funes, H ;
Cervantes, A ;
Freyer, G ;
Papamichael, D ;
Le Bail, N ;
Louvet, C ;
Hendler, D ;
de Braud, F ;
Wilson, C ;
Morvan, F ;
Bonetti, A .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2938-2947